Skip to main content

UBS Group AG

Position in PRME — Prime Medicine, Inc.

CIK 1610520 ZURICH, V8

Position in PRME

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,312,400
+$260,707 QoQ
Shares Held
2,794,689
-3.2% QoQ
Ownership
1.54%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. PRME ranks #112 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,312,400 2,794,689
2026-03-31 $10,051,693 2,888,418
2025-12-31 $8,468,821 2,440,583
2025-09-30 $1,688,441 304,773
2025-06-30 $482,457 195,327
2025-03-31 $234,183 117,680
2024-12-31 $637,102 218,186
2024-09-30 $135,530 35,021
2024-06-30 $115,850 22,539
2024-03-31 $297,661 42,523
2023-12-31 $278,309 31,412
2023-09-30 $417,584 43,772
2023-06-30 $1,450,921 99,039
2023-03-31 $60,699 4,935
2022-12-31 $22,462 1,209